FARAONI, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 11.079
AS - Asia 1.612
EU - Europa 1.434
SA - Sud America 251
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 24
OC - Oceania 3
Totale 14.553
Nazione #
US - Stati Uniti d'America 11.001
SG - Singapore 707
CN - Cina 341
IT - Italia 296
BR - Brasile 208
DE - Germania 196
RU - Federazione Russa 184
HK - Hong Kong 150
UA - Ucraina 142
VN - Vietnam 129
IE - Irlanda 118
FI - Finlandia 114
GB - Regno Unito 110
FR - Francia 93
SE - Svezia 73
BD - Bangladesh 64
JP - Giappone 52
CA - Canada 45
IN - India 41
KR - Corea 35
ID - Indonesia 26
NL - Olanda 20
AR - Argentina 18
BE - Belgio 18
PL - Polonia 17
MX - Messico 14
AT - Austria 13
ES - Italia 12
ZA - Sudafrica 11
CO - Colombia 10
AL - Albania 8
PH - Filippine 8
SA - Arabia Saudita 8
EC - Ecuador 6
JM - Giamaica 6
CR - Costa Rica 5
IQ - Iraq 5
KG - Kirghizistan 5
MY - Malesia 5
TR - Turchia 5
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
IL - Israele 3
LB - Libano 3
LT - Lituania 3
TN - Tunisia 3
AZ - Azerbaigian 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SY - Repubblica araba siriana 2
VE - Venezuela 2
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KZ - Kazakistan 1
MD - Moldavia 1
NG - Nigeria 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 14.405
Città #
Woodbridge 2.859
Houston 2.624
Wilmington 2.459
Singapore 417
Ann Arbor 314
Ashburn 274
San Jose 233
Chandler 196
Fairfield 193
Hong Kong 146
Council Bluffs 127
Jacksonville 123
Beijing 121
New York 111
Dublin 97
Dearborn 93
Seattle 85
Rome 80
Helsinki 77
Cambridge 75
Medford 75
Santa Clara 62
The Dalles 59
Dallas 56
Ho Chi Minh City 46
Los Angeles 46
Tokyo 43
Lawrence 34
Buffalo 29
Hanoi 24
Moscow 23
Mülheim 23
Menlo Park 21
Lauterbourg 20
Brussels 18
Munich 18
Boardman 17
San Diego 17
São Paulo 17
Del Norte 16
Falls Church 16
Milan 16
Ottawa 16
Jakarta 15
Chicago 14
Frankfurt am Main 14
Hangzhou 14
Orem 14
Palo Alto 14
Phoenix 14
Zhengzhou 12
Florence 11
Kraków 11
Redondo Beach 11
Nuremberg 10
Belo Horizonte 9
Brooklyn 9
Perugia 9
Redwood City 9
Curitiba 8
Dong Ket 8
Engelhard 8
London 8
Salt Lake City 8
University Park 8
Vienna 8
Boston 7
Charlotte 7
Mountain View 7
Philadelphia 7
Seoul 7
Toronto 7
Atlanta 6
Brasília 6
Johannesburg 6
Marseille 6
Montreal 6
Nanjing 6
South Tangerang 6
Washington 6
Guangzhou 5
Hyderabad 5
Jeddah 5
Kingston 5
North Bergen 5
Norwalk 5
Rio de Janeiro 5
Springfield 5
Turku 5
Verona 5
Warsaw 5
Amsterdam 4
Chennai 4
Contagem 4
Da Nang 4
Hefei 4
Lappeenranta 4
Lucknow 4
Mexico City 4
Naples 4
Totale 11.843
Nome #
BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib. 563
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro 524
Preclinical studies on detection of circulating melanoma cells in patients: Telomerase as a recognition marker of malignancy 508
Comparative antiviral and antiproliferative activity of PGA1 and PGJ2 against HTLV-1-infected MT-2 cells. 480
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro 475
Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells 472
Modulation of GDF11 expression and synaptic plasticity by age and training 456
COMPARATIVE ANTIVIRAL AND ANTIPROLIFERATIVE ACTIVITY OF PGA1 AND PGJ2 AGAINST HTLV-I-INFECTED MT-2 CELLS 454
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype 452
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro 442
Effect of beta interferon on HTLV I infection of fractionated T cells 441
Inhibition of O-6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic coils to apoptosis induced by temozolomide 437
Telomerase as a potential anticancer target: growth inhibition and genomic instability 422
Clinical applications of telomerase in cancer treatment 422
In vitro measurement of ovarian cancer cells chemosensitivity to antineoplastic drugs as inhibition of telomerase activity 409
Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells 403
Telomerase as a marker of tumor cell viability: A new approach for in vitro chemosensitivity assays? 395
Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples 390
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 383
Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival 380
Transient HTLV-I infection of a human glioma cell line following cell-free exposure 379
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status. 374
Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-Ribose) polymerase 368
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 367
Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells 360
The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation. 354
PROTECTIVE EFFECT OF INTERFERON-BETA ON HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I INFECTION OF CD4+ T-CELLS ISOLATED FROM HUMAN CORD-BLOOD 328
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes 321
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line 297
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 285
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers 270
Role of BRCA mutations in cancer treatment with poly(ADP-ribose) polymerase (PARP) inhibitors 244
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders 188
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? 176
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 161
Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C 141
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients 132
Polydatin-Induced Shift of Redox Balance and Its Anti-Cancer Impact on Human Osteosarcoma Cells 128
miR-155 gene: A typical multifunctional microRNA 95
Combination treatment of resistant acute promyelocytic leukemia cells with arsenic trioxide and anti-apoptotic gene inhibitors 86
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias 84
HSP70 production and inhibition of cell proliferation in molt-4 T-cells after cell-to-cell transmission of HTLV-I: Effect of PGA1 71
In vitro chemosensitivity of neoplastic cells: Telomerase as a possible marker of tumor cell survival 68
A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro 63
Nerve growth factor induces the re-expression of functional androgen receptors and p75NGFR in the androgen-insensitive prostate cancer cell line DU145 58
Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro 56
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation 56
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines 49
Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene 48
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications 38
Totale 14.553
Categoria #
all - tutte 34.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022378 0 0 29 38 25 40 28 27 26 32 28 105
2022/2023492 44 41 7 81 46 110 49 21 40 1 31 21
2023/2024321 21 6 23 3 32 114 15 6 5 5 45 46
2024/20251.132 110 198 97 52 34 73 90 80 163 65 84 86
2025/20262.232 203 110 259 173 202 81 328 266 262 166 109 73
2026/2027339 131 111 97 0 0 0 0 0 0 0 0 0
Totale 14.553